Works matching DE "RIMONABANT"

Results: 105

One‐Pot Double Oxidation Synthesis of N‐1‐Piperidonyl Amides From N‐1‐Piperidinyl Amides with meta‐Chloroperbenzoic Acid: Rimonabant Analogue as Model Study.

Published in:

Chemistry - A European Journal, 2023, v. 29, n. 45, p. 1, doi. 10.1002/chem.202300702

By:

Chen, Yu‐Chieh;
Zeng, Wei‐Zheng;
Li, Sin‐Min;
Chou, Jia‐Yu;
Tsai, Shuo‐En;
Fuh Wong, Fung

Publication type:

Article

Rimonabant Precipitates Anxiety in Rats Withdrawn from Palatable Food: Role of the Central Amygdala.

Published in:

Neuropsychopharmacology, 2013, v. 38, n. 12, p. 2498, doi. 10.1038/npp.2013.153

By:

Blasio, Angelo;
Iemolo, Attilio;
Sabino, Valentina;
Petrosino, Stefania;
Steardo, Luca;
Rice, Kenner C;
Orlando, Pierangelo;
Iannotti, Fabio Arturo;
Di Marzo, Vincenzo;
Zorrilla, Eric P;
Cottone, Pietro

Publication type:

Article

Genetic Deletion of Fatty Acid Amide Hydrolase Alters Emotional Behavior and Serotonergic Transmission in the Dorsal Raphe, Prefrontal Cortex, and Hippocampus.

Published in:

Neuropsychopharmacology, 2010, v. 35, n. 10, p. 2083, doi. 10.1038/npp.2010.80

By:

Bambico, Francis Rodriguez;
Cassano, Tommaso;
Dominguez-Lopez, Sergio;
Katz, Noam;
Walker, Claire Dominique;
Piomelli, Daniele;
Gobbi, Gabriella

Publication type:

Article

A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia.

Published in:

Neuropsychopharmacology, 2010, v. 35, n. 6, p. 1315, doi. 10.1038/npp.2009.235

By:

Tiwari, Arun K.;
Zai, Clement C.;
Likhodi, Olga;
Lisker, Annika;
Singh, Deepika;
Souza, Renan P.;
Batra, Poonam;
Zaidi, Syed H. E.;
Sheng Chen;
Fang Liu;
Puls, Imke;
Meltzer, Herbert Y.;
Lieberman, Jeffrey A.;
Kennedy, James L.;
Müller, Daniel J

Publication type:

Article

Synthesis and Anticancer Activity of 1,2,3-Triazole Fused N-Arylpyrazole Derivatives.

Published in:

Russian Journal of General Chemistry, 2019, v. 89, n. 4, p. 831, doi. 10.1134/S1070363219040315

By:

Lakkakula, R.;
Roy, A.;
Mukkanti, K.;
Sridhar, G.

Publication type:

Article

Tethered agonist activated ADGRF1 structure and signalling analysis reveal basis for G protein coupling.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38083-7

By:

Jones, Daniel T. D.;
Dates, Andrew N.;
Rawson, Shaun D.;
Burruss, Maggie M.;
Lipper, Colin H.;
Blacklow, Stephen C.

Publication type:

Article

Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model.

Published in:

Genes, 2016, v. 7, n. 9, p. 56, doi. 10.3390/genes7090056

By:

Gomis-González, Maria;
Busquets-Garcia, Arnau;
Matute, Carlos;
Maldonado, Rafael;
Mato, Susana;
Ozaita, Andrés

Publication type:

Article

Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.

Published in:

Journal of Psychopharmacology, 2012, v. 26, n. 1, p. 125, doi. 10.1177/0269881111400649

By:

Horder, Jamie;
Browning, Michael;
Di Simplicio, Martina;
Cowen, Philip J;
Harmer, Catherine J

Publication type:

Article

Effects of Rimonabant, as Monotherapy and in Combination With Fenofibrate or Ezetimibe, on Plasma Adipokine Levels: A Pilot Study.

Published in:

Angiology, 2010, v. 61, n. 4, p. 365, doi. 10.1177/0003319709352488

By:

Florentin, Matilda;
Liberopoulos, Evangelos N.;
Tellis, Costas C.;
Derdemezis, Christos S.;
Elisaf, Moses;
Tselepis, Alexandros

Publication type:

Article

Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators.

Published in:

2022

By:

García-Vega, David;
González-Juanatey, José Ramón;
Eiras, Sonia

Publication type:

Literature Review

Rimonabant suppresses RNA transcription of hepatitis B virus by inhibiting hepatocyte nuclear factor 4α.

Published in:

Microbiology & Immunology, 2020, v. 64, n. 5, p. 345, doi. 10.1111/1348-0421.12777

By:

Sato, Asuka;
Ono, Chikako;
Tamura, Tomokazu;
Mori, Hiroyuki;
Izumi, Takuma;
Torii, Shiho;
Fauzyah, Yuzy;
Yamamoto, Takuya;
Morioka, Yuhei;
Okuzaki, Daisuke;
Fukuhara, Takasuke;
Matsuura, Yoshiharu

Publication type:

Article

Rehabilitating rimonabant.

Published in:

2013

By:

Luft, Friedrich

Publication type:

Editorial

Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.

Published in:

Biochemistry (00062979), 2019, v. 84, n. 8, p. 954, doi. 10.1134/S000629791908011X

By:

Müller, G. A.;
Wied, S.;
Herling, A. W.

Publication type:

Article

Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE).

Published in:

Family Practice, 2012, v. 29, n. 5, p. 521, doi. 10.1093/fampra/cms013

By:

Boesten, Jolien E J;
Kaper, Janneke;
Stoffers, Henri E J H;
Kroon, Abraham A;
van Schayck, Onno C P

Publication type:

Article

Direct and Indirect Effects of Cannabinoids on in vitro GABA Release in the Rat Arcuate Nucleus.

Published in:

Journal of Neuroendocrinology, 2010, v. 22, n. 6, p. 585, doi. 10.1111/j.1365-2826.2010.01990.x

By:

Menzies, J. R. W.;
Ludwig, M.;
Leng, G.

Publication type:

Article

The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake.

Published in:

British Journal of Clinical Pharmacology, 2014, v. 77, n. 1, p. 21, doi. 10.1111/bcp.12102

By:

Cooper, Martin E.;
Regnell, Simon E.

Publication type:

Article

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 6, p. 846, doi. 10.1111/bcp.12141

By:

Klumpers, Linda E.;
Fridberg, Marianne;
Kam, Marieke L.;
Little, Paul B.;
Jensen, Niels Ole;
Kleinloog, Hendrik D.;
Elling, Christian E.;
Gerven, Joop M. A.

Publication type:

Article

Pharmacotherapy for obesity.

Published in:

British Journal of Clinical Pharmacology, 2009, v. 68, n. 6, p. 804, doi. 10.1111/j.1365-2125.2009.03453.x

By:

Mingfang Li;
Cheung, Bernard M. Y.

Publication type:

Article

INVENTIVE MEDICINES - COSTLY MIRACLES OR MAYH EM OF THE MODERN SCIENCE.

Published in:

Review of Economic Studies & Research Virgil Madgearu, 2012, v. 5, n. 2, p. 139

By:

KESIČ, Dragan;
BERTONCELJ, Andrej

Publication type:

Article

Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.

Published in:

Journal of Neuroscience, 2017, v. 37, n. 3, p. 626, doi. 10.1523/JNEUROSCI.1310-16.2017

By:

Ming-Hua Li;
Suchland, Katherine L.;
Ingram, Susan L.

Publication type:

Article

Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2009, v. 14, n. 4, p. 274, doi. 10.1177/1074248409343935

By:

Florentin, Matilda;
Kostapanos, Michael S.;
Nakou, Eleni S.;
Elisaf, Moses;
Liberopoulos, Evangelos N.

Publication type:

Article

A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats.

Published in:

Acta Neuropsychiatrica, 2017, v. 29, n. 6, p. 324, doi. 10.1017/neu.2016.68

By:

Kirkedal, Christian;
Wegener, Gregers;
Moreira, Fabricio;
Joca, Sâmia Regiane Lourenco;
Liebenberg, Nico

Publication type:

Article

The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.

Published in:

International Journal of Neuropsychopharmacology, 2016, v. 19, n. 12, p. 1, doi. 10.1093/ijnp/pyw068

By:

Gueye, Aliou B.;
Pryslawsky, Yaroslaw;
Trigo, Jose M.;
Poulia, Nafsika;
Delis, Foteini;
Antoniou, Katerina;
Loureiro, Michael;
Laviolette, Steve R.;
Vemuri, Kiran;
Makriyannis, Alexandros;
Le Foll, Bernard

Publication type:

Article

The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers.

Published in:

International Journal of Neuropsychopharmacology, 2016, v. 19, n. 2, p. 1, doi. 10.1093/ijnp/pyv092

By:

Rzepa, Ewelina;
Tudge, Luke;
McCabe, Ciara

Publication type:

Article

Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers.

Published in:

International Journal of Neuropsychopharmacology, 2015, v. 18, n. 6, p. 1, doi. 10.1093/ijnp/pyu094

By:

Tudge, Luke;
Williams, Clare;
Cowen, Philip J.;
McCabe, Ciara

Publication type:

Article

Pleiotropic effects of Rimonabant and Simvastatin on obesity associated multiple metabolic risk factors in rats.

Published in:

European Review for Medical & Pharmacological Sciences, 2012, v. 16, n. 6, p. 797

By:

SALEM, N.A.;
ASSAF, N.;
AHMED, H.H.

Publication type:

Article

Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice.

Published in:

Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1100527

By:

Marinho, Eduardo A. V.;
Justo Oliveira-Lima, Alexandre;
Reis, Henrique S.;
Santos-Baldaia, Renan;
Wuo-Silva, Raphael;
Hollais, Andre W.;
Yokoyama, Thais S.;
Frussa-Filho, Roberto;
Berro, Lais F.

Publication type:

Article

Effect of rimonabant on oesophageal motor function in man.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 6, p. 730, doi. 10.1111/j.1365-2036.2011.04576.x

By:

Scarpellini, E.;
Blondeau, K.;
Boecxstaens, V.;
Vos, R.;
Gasbarrini, A.;
Farré, R.;
Tack, J.

Publication type:

Article

Endocannabinoid control of gastric sensorimotor function in man.

Published in:

Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 10, p. 1123, doi. 10.1111/j.1365-2036.2010.04259.x

By:

AMELOOT, K.;
JANSSEN, P.;
SCARPELLINI, E.;
VOS, R.;
BOESMANS, W.;
DEPOORTERE, I.;
VANDEN BERGHE, P.;
TACK, J.

Publication type:

Article

Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.

Published in:

Canadian Journal of Physiology & Pharmacology, 2014, v. 92, n. 12, p. 975, doi. 10.1139/cjpp-2014-0310

By:

Patel, Kartikkumar Navinchandra;
Joharapurkar, Amit Arvind;
Patel, Vishal;
Kshirsagar, Samadhan Govind;
Bahekar, Rajesh;
Srivastava, Brijesh Kumar;
Jain, Mukul R.

Publication type:

Article

Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait.

Published in:

Neural Plasticity, 2015, v. 2015, p. 1, doi. 10.1155/2016/6481862

By:

Rodríguez-Arias, M.;
Roger-Sánchez, C.;
Vilanova, I.;
Revert, N.;
Manzanedo, C.;
Miñarro, J.;
Aguilar, M. A.

Publication type:

Article

Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 6, p. 2281, doi. 10.1159/000480001

By:

He, Xiaolie;
Yang, Li;
Wang, Mei;
Zhuang, Xizhen;
Huang, Ruiqi;
Zhu, Rongrong;
Wang, Shilong

Publication type:

Article

Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.

Published in:

International Journal of Neuropsychopharmacology, 2010, v. 13, n. 8, p. 1103, doi. 10.1017/S1461145710000453

By:

Horder, Jamie;
Harmer, Catherine J.;
Cowen, Philip J.;
McCabe, Ciara

Publication type:

Article

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.

Published in:

Cardiovascular Research, 2010, v. 85, n. 4, p. 773, doi. 10.1093/cvr/cvp369

By:

Mukhopadhyay, Partha;
Rajesh, Mohanraj;
Bátkai, Sándor;
Patel, Vivek;
Kashiwaya, Yoshihiro;
Liaudet, Lucas;
Evgenov, Oleg V.;
Mackie, Ken;
Haskó, György;
Pacher, Pál

Publication type:

Article

Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors.

Published in:

Nature Medicine, 2011, v. 17, n. 10, p. 1228, doi. 10.1038/nm.2435

By:

Benedetti, Fabrizio;
Amanzio, Martina;
Rosato, Rosalba;
Blanchard, Catherine

Publication type:

Article

Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant.

Published in:

Nutrition Journal, 2012, v. 11, p. 50, doi. 10.1186/1475-2891-11-50

By:

Heppenstall, Charlotte;
Bunce, Susan;
Smith, Jamie C

Publication type:

Article

Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway.

Published in:

Acta Pharmacologica Sinica, 2010, v. 31, n. 11, p. 1447, doi. 10.1038/aps.2010.126

By:

Nan-lan HUANG;
Jyh-ming JUANG;
Yi-ho WANG;
Chia-hsiang HSUEH;
Yao-jen LIANG;
Jiunn-lee LIN;
Chia-ti TSAI;
Ling-ping LAI

Publication type:

Article

Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators.

Published in:

Amino Acids, 2018, v. 50, n. 11, p. 1595, doi. 10.1007/s00726-018-2636-1

By:

Stefanucci, Azzurra;
Macedonio, Giorgia;
Dvorácskó, Szabolcs;
Tömböly, Csaba;
Mollica, Adriano

Publication type:

Article

Pyrrole‐Thiazolidin‐4‐one Analogues Exhibit Promising Anti‐Tuberculosis Activity.

Published in:

Asian Journal of Organic Chemistry, 2024, v. 13, n. 6, p. 1, doi. 10.1002/ajoc.202400054

By:

Ahmed, Shujauddin;
Mital, Alka;
Akhir, Abdul;
Saxena, Deepanshi;
Jahan, Kousar;
Dubey, Gurudutt;
Bharatam, P. V.;
Dasgupta, Arunava;
Chopra, Sidharth;
Jain, Rahul

Publication type:

Article

Effect of rimonabant and metformin on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in obese women with polycystic ovary syndrome.

Published in:

2010

By:

Sathyapalan, Thozhukat;
Cho, LiWei;
Kilpatrick, Eric S.;
Le Roux, Carel W.;
Coady, Anne-Marie;
Atkin, Stephen L.

Publication type:

Letter

RP-HPLC Method Development and Its Validation for Quantitative Determination of Rimonabant in Human Plasma.

Published in:

Journal of Analytical Methods in Chemistry, 2012, p. 1, doi. 10.1155/2012/625979

By:

Bankey, Shravan;
Tapadiya, Ganesh;
Lamale, Jasvant;
Jain, Deepti;
Saboo, Shweta;
Khadabadi, S. S.

Publication type:

Article

A Novel and Practical Synthesis of Rimonabant Hydrochloride.

Published in:

Organic Preparations & Procedures International, 2012, v. 44, n. 2, p. 164, doi. 10.1080/00304948.2012.657564

By:

Fang, Zheng;
Yang, Zhao;
Xu, Jia-Feng;
Guo, Kai;
Wei, Ping

Publication type:

Article

CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.

Published in:

PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0206152

By:

Chang, Eugene;
Kim, Dae-Hee;
Yang, Hyekyung;
Lee, Da Hyun;
Bae, Soo Han;
Park, Cheol-Young

Publication type:

Article

New obesity treatment improves glucose control.

Published in:: British Journal of Hospital Medicine (17508460), 2008, v. 69, n. 7, p. 377
Publication type:: Article

RP-HPLC Method Development and its Validation for Quantitative Determination of Rimonabant in Human Plasma.

Published in:

Eurasian Journal of Analytical Chemistry, 2012, v. 7, n. 3, p. 115

By:

Bankey, Shravan K.;
Jain, Surendra K.;
Basniwal, Pawan K.;
Jain, Deepti

Publication type:

Article

Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.

Published in:

Journal of Neurochemistry, 2010, v. 112, n. 5, p. 1338, doi. 10.1111/j.1471-4159.2009.06549.x

By:

Martín-García, Elena;
Burokas, Aurelijus;
Martín, Miquel;
Berrendero, Fernando;
Rub, Blanca;
Kiesselbach, Christoph;
Heyne, Andrea;
Gispert, Juan Domingo;
Millán, Olga;
Maldonado, Rafael

Publication type:

Article

Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes.

Published in:

Yonsei Medical Journal, 2013, v. 54, n. 5, p. 1127, doi. 10.3349/ymj.2013.54.5.1127

By:

Sang-Man Jin;
Bae Jun Oh;
Suel Lee;
Jung Mook Choi;
Soo Jin Yang;
Sung Woo Park;
Kwang-Won Kim;
Jae Hyeon Kim;
Cheol-Young Park

Publication type:

Article

Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 1, p. 94, doi. 10.1002/hup.2374

By:

Bergamaschi, Mateus M.;
Queiroz, Regina H. C.;
Chagas, Marcos H. N.;
Linares, Ila M. P.;
Arrais, Kátia C.;
Oliveira, Danielle C. G.;
Queiroz, Maria E.;
Nardi, Antonio E.;
Huestis, Marilyn A.;
Hallak, Jaime E. C.;
Zuardi, Antonio W.;
Moreira, Fabrício A.;
Crippa, José A. S.

Publication type:

Article

Positron Emission Tomographic Imaging of the Cannabinoid Type 1 Receptor System with [11C]OMAR ([11C]JHU75528): Improvements in Image Quantification Using Wild-Type and Knockout Mice.

Published in:

Molecular Imaging, 2011, v. 10, n. 6, p. 481, doi. 10.2310/7290.2011.00019s

By:

Herance, Raúl;
Rojas, Santiago;
Abad, Sergio;
Jiménez, Xavier;
Gispert, Juan Domingo;
Millán, Olga;
Martín-García, Elena;
Burokas, Aurelijus;
Serra, Miquel Àngel;
Maldonado, Rafael;
Pareto, Deborah

Publication type:

Article

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2017, v. 32, n. 1, p. 444, doi. 10.1080/14756366.2016.1260565

By:

Mollica, Adriano;
Pelliccia, Sveva;
Famiglini, Valeria;
Stefanucci, Azzurra;
Macedonio, Giorgia;
Chiavaroli, Annalisa;
Orlando, Giustino;
Brunetti, Luigi;
Ferrante, Claudio;
Pieretti, Stefano;
Novellino, Ettore;
Benyhe, Sandor;
Zador, Ferenc;
Erdei, Anna;
Szucs, Edina;
Samavati, Reza;
Dvorácskó, Szabolcs;
Tomboly, Csaba;
Ragno, Rino;
Patsilinakos, Alexandros

Publication type:

Article